Sign in
4

Changes in Ownership

4D Molecular Therapeutics, Inc. Filed Acc 0001834021-26-000004

See Remarks sold 58,333 shares at an average $12.64 ($737,410)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Kirn David See Remarks 2026-07-09 Sale 10b5-1 −42,608 $12.87 $548,177 899,877 D: show line 1 in the form
Kirn David See Remarks 2026-07-10 Sale 10b5-1 −15,283 $12.01 $183,560 884,594 D: show line 2 in the form
Kirn David See Remarks 2026-07-10 Sale 10b5-1 −442 $12.84 $5,673 884,152 D: show line 3 in the form
Open-market sales · 58,333 sh · avg $12.64 · $737,410
Loading xslF345X06/ownership.xml…